Literaturverzeichnis

Literatur zum HS-Omega-3 Index®

  • 197. van der Wurff ISM, von Schacky C, Berge K, Kirschner PA, de Groot RHM. Protocol for a randomised controlled trial investigating the effect of increasing Omega-3 index with krill oil supplementation on learning, cognition, behaviour and visual processing in typically developing adolescents. BMJ Open 2016, in press
  • 196. von Schacky C. w-3 Fettsäuren und Hirnfunktion. Orthomol Med 2016, in press
  • 195. Jin Y, Kim TH, Park Y. Association between erythrocyte levels of n-3 polyunsaturated fatty acids and depression in postmenopausal women using or not using hormone therapy. Menopause. E-pub 2016 Jun 13.
  • 194. Monge A, Harris WS, Ortiz-Panozo E, Yunes E, Cantu-Brito C, Catzin-Kuhlmann A, López-Ridaura R, Lajous M. Whole Blood ω-3 Fatty Acids Are Inversely Associated with Carotid Intima-Media Thickness in Indigenous Mexican Women. J Nutr. E-pub 2016 Jun 8.
  • 193. Schuchardt JP, Köbe T, Witte V, Willers J, Gingrich A, Tesky V, Pantel J, Rujescu D, Illig T, Flöel A, Hahn A. Genetic variants of the FADS gene cluster are associated with erythrocyte membrane LC PUFA levels in patients with mild cognitive impairment. J Nutr Health Ageing 2016;20:611-20
  • 192. Gellert S, Schuchardt JP, Hahn A. Higher Omega-3 Index and DHA status in pregnant women compared to lactating women – Results from a German nation-wide cross-sectional study. Prostaglandins Leukot Essent Fatty Acids. 2016;109:22-28
  • 191. Cho E, Park Y. Association between serum fatty acid composition and innate immune markers in healthy adults. Nutr Res Pract 2016;10:182-7.
  • 190. Jumbe T, Comstock SS, Hahn SL, Harris WS, Kinabo J, Fenton JI. Whole Blood Levels of the n-6 Essential Fatty Acid Linoleic Acid Are Inversely Associated with Stunting in 2-to-6 Year Old Tanzanian Children: A Cross-Sectional Study. PLoS One. 2016; 3;11:e0154715.
  • 189. von Schacky C, Passow A, Kiefl R. Trans Fatty Acid Levels in Erythrocytes in Europe. Eur J Nutr 2016, e-pub May 5
  • 188. Mehler SJ, Maya LR, King C, Harris WS, Shah Z. A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. Prostaglandins Leukot Essent Fatty Acids. 2016;109:1-7
  • 187. Harris WS. Could erythrocyte omega-3 fatty acid levels be harbingers of bipolar disorder? Early Interv Psychiatry. 2016;10:191-2
  • 186. Lupton JR, Blumberg JB, L’Abbe M, LeDoux M, Rice HB, von Schacky C, Yaktine A, Griffiths JC. Nutrient reference value: non-communicable disease – a conference report. Eur J Nutr 2016, e-pub March 16
  • 185. Messamore E, McNamara RK. Detection and treatment of omega-3 fatty acid deficiency in psychiatric practice: Rationale and implementation. Lipids Health Dis. 2016;15:25.
  • 184. Bigornia SJ, Harris WS, Falcón LM, Ordovás JM, Lai CQ, Tucker KL. The Omega-3 Index Is Inversely Associated with Depressive Symptoms among Individuals with Elevated Oxidative Stress Biomarkers. J Nutr. 2016;146:758-66, e-pub Mar 2.
  • 183. Carney RM, Steinmeyer BC, Freedland KE, Rubin EH, Rich MW, Harris WS. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements. J Clin Psychiatry. 2016;77:e138-43
  • 182. Harris WS, Luo J, Pottala JV, Margolis KL, Espeland MA, Robinson JG. Red Blood Cell Fatty Acids and Incident Diabetes Mellitus in the Women's Health Initiative Memory Study. PLoS One. 2016;16;11:e0147894.
  • 181. Bigornia SJ, Lichtenstein AH, Harris WS, Tucker KL. Associations of erythrocyte fatty acid patterns with insulin resistance. Am J Clin Nutr. 2016;103:902-9, e-pub Feb 10.
  • 180. Rice HB, Bernasconi A, Maki KC, Harris WS, von Schacky C, Calder PC. Conducting omega-3 clinical trials with cardiovascular outcomes: Proceedings of a workshop held at ISSFAL 2014. Prostaglandins Leukot Essent Fatty Acids. 2016;107:30-42, e-pub Jan 25
  • 179. van der Wurff ISM, von Schacky C, Berge K, Zeegers MP, Kirschner PA, de Groot RHM. Positive association between blood Omega-3 index and cognition in healthy Dutch adolescents. Nutrients. 2016;8:13
  • 178. DeFina LF, Bassett MH, Finley CE, Barlow CE, Willis BL, Cooper T, Clark SM, Harris WS, Radford NB. Association between omega-3 fatty acids and serum prostate-specific antigen. Nutr Cancer. 2015 Dec 28:1-5. [Epub ahead of print]
  • 177. Oh Y, Jin Y, Park Y. Synergic hypocholesterolaemic effect of n-3 PUFA and oestrogen by modulation of hepatic cholesterol metabolism in female rats. Br J Nutr. 2015 Dec 14;114:1766-73.
  • 176. Lee SM, Chung SH, Park Y, Park MK, Son YK, Kim SE, An WS. Effect of Omega-3 Fatty Acid on the Fatty Acid Content of the Erythrocyte Membrane and Proteinuria in Patients with Diabetic Nephropathy. Int J Endocrinol. 2015;2015:208121.
  • 175. Harris WS, Kennedy KF, Maddox TM, Kutty S, Spertus JA. Multiple differences between patients who initiate fish oil supplementation post-myocardial infarction and those who do not: the TRIUMPH Study. Nutr Res. 2016;36:65-71. E-pub 2015 Nov 14.
  • 174. von Schacky C. Omega-3 Fettsäuren im Sport. Vitalstoffe 2015;5/4:10-16
  • 173. Langlois K, Ratnayake WMN. Omega-3 Index of Canadian Adults. Statistics Canada, Catalogue No. 82-003-X. Health Reports 2015;26:3-11
  • 172. Köbe T, Witte AV, Schnelle A, Lesemann A, Fabian S, Tesky VA, Pantel J, Flöel A. Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment. Neuroimage. E-pub 2015 Oct 1.
  • 171. Jin Y, Park Y. N-3 polyunsaturated fatty acids and 17beta-estradiol injection induce antidepressant-like effects through regulation of serotonergic neurotransmission in ovariectomized rats. J Nutr Biochem 2015;26:970-77.
  • 170. Kim S, Jin Y, Park Y. Estrogen and n-3 polyunsaturated fatty acid supplementation have a synergistic hypotriglyceridemic effect in ovariectomized rats. Genes Nutr 2015;10:475.
  • 169. Reese I, Werfel T. Schützen langkettige omega-3 Fettsäuren vor atopischer Dermatitis? J Dtsch Dermatol Ges 2015;13:879-85
  • 168. Kleber ME, Delgado DE, Lorkowski S, März W, von Schacky C. Trans Fatty Acids and Mortality in Patients referred for Coronary Angiography - The Ludwigshafen Risk and Cardiovascular Health Study. Eur Heart J 2016;37:1072-82; e-pub Sep 22, 2015
  • 167. Grenon SM, Owens CD, Nosova EV, Hughes-Fulford M, Alley HF, Chong K, Perez S, Yen PK, Boscardin J, Hellmann J, Spite M, Conte MS. Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial). J Am Heart Assoc. 2015 Aug 21;4(8):e002034.
  • 166. Ebbesson SO, Voruganti VS, Higgins PB, Fabsitz RR, Ebbesson LO, Laston S, Harris WS, Kennish J, Umans BD, Wang H, Devereux RB, Okin PM, Weissman NJ, MacCluer JW, Umans JG, Howard BV. Fatty acids linked to cardiovascular mortality are associated with risk factors. Int J Circumpolar Health. E-pub 2015;74:28055.
  • 165. Skulas-Ray AC, Flock MR, Richter CK, Harris WS, West SG, Kris-Etherton PM. Red Blood Cell Docosapentaenoic Acid (DPA n-3) is Inversely Associated with Triglycerides and C-reactive Protein (CRP) in Healthy Adults and Dose-Dependently Increases Following n-3 Fatty Acid Supplementation. Nutrients. 2015;7:6390-404
  • 164. Baack ML, Puumala SE, Messier SE, Pritchett DK, Harris WS. What is the relationship between gestational age and docosahexaenoic acid (DHA) and arachidonic acid (ARA) levels? Prostaglandins Leukot Essent Fatty Acids. 2015;100:5-11, e-pub 2015 Jun 17.
  • 163. Park Y, Park YS, Kim SH, Oh DH, Park YC. Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea. Ann Nutr Metab. 2015;66:141-8, e-pub Mar 24
  • 162. de Ferranti SD, Milliren CE, Denhoff ER, Steltz SK, Selamet Tierney ES, Feldman HA, Osganian SK. Using high-dose omega-3 fatty acid supplements to lower triglyceride levels in 10- to 19-year-olds. Clin Pediatr (Phila). 2014;53:428-38.
  • 161. Zaalberg A, Wielders J, Bulten E, van der Staak C, Wouters A, Nijman H. Relationships of diet-related blood parameters and blood lead levels with psychopathology and aggression in forensic psychiatric inpatients. Crim Behav Ment Health. E-pub 2015 Mar 31.
  • 160. Fontes JD, Rahman F, Lacey S, Larson MG, Vasan RS, Benjamin EJ, Harris WS, Robins SJ. Red blood cell fatty acids and biomarkers of inflammation: A cross-sectional study in a community-based cohort. Atherosclerosis. 2015;240:431-436
  • 159. Harris WS. Pushing the limits with omega-3 fatty acids. Trends Cardiovasc Med. E-pub 2015 Mar 16.
  • 158. Schmidt S, Willers J, Riecker S, Möller K, Schuchardt JP, Hahn A. Effect of omega-3 polyunsaturated fatty acids on the cytoskeleton: an open-label intervention study. Lipids Health Dis. 2015 Feb 14;14:4.
  • 157. Naesgaard PA, Pönitz V, Aarsetoey H, Brügger-Andersen T, Grundt H, Harris WS, Staines H, Nilsen DW. Prognostic utility of vitamin d in acute coronary syndrome patients in coastal norway. Dis Markers. 2015;2015:283178.
  • 156. Lee SM, Son YK, Kim SE, An WS. The effects of omega-3 Fatty Acid on vitamin d activation in hemodialysis patients: a pilot study. Mar Drugs. 2015;13:741-55.
  • 155. Kaess BM, Harris WS, Lacey S, Larson MG, Hamburg NM, Vita JA, Robins SJ, Benjamin EJ, Mitchell GF, Vasan RS. The relation of red blood cell fatty acids with vascular stiffness, cardiac structure and left ventricular function: The Framingham Heart Study. Vasc Med. 2015;20:5-13; e-pub 2014 Dec 17.
  • 154. Hedengran A, Szecsi PB, Dyerberg J, Harris WS, Stender S. n-3 PUFA Esterified to Glycerol or as Ethyl Esters Reduce Non-Fasting Plasma Triacylglycerol in Subjects with Hypertriglyceridemia: A Randomized Trial. Lipids 2015;50:165-76, e-pub 2014 Nov 18
  • 153. Voggt A, Berger M, Obermeier M, Löw A, Seemüller F, Riedel M, Moeller HJ, Zimmermann R, Kirchberg F, von Schacky C, Severus E. Heart rate variability and omega-3 index in euthymic patients with bipolar disorders. Eur Psy 2015:30:228-32, e-pub 2014 Dec 30
  • 152. von Schacky C. Sinn und Unsinn. Vitamine und Supplemente in der Kardiologie. Akt Kard 2014;3:375-9
  • 151. Nagasaka R, Gagnon C, Swist E, Rondeau I, Massarelli I, Cheung W, Ratnayake WM. EPA and DHA status of South Asian and white Canadians living in the National Capital Region of Canada. Lipids. 2014;49:1057-69, e-pub 2014 Aug 23
  • 150. Flock MR, Skulas-Ray AC, Harris WS, Gaugler TL, Fleming JA, Kris-Etherton PM. Effects of supplemental long-chain omega-3 fatty acids and erythrocyte membrane fatty acid content on circulating inflammatory markers in a randomized controlled trial of healthy adults. Prostaglandins Leukot Essent Fatty Acids 2014;91:161-8, e-pub Jul 17.
  • 149. Schuchardt JP, Neubronner J, Block RC, von Schacky C, Hahn A. Associations between omega-3 index increase and triglyceride decrease in hypertriglyceridemic patients in response to supplementation with long chain omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2014;91:129-34, e-pub 2014 July 14
  • 148. Gidding SS, Prospero C, Hossain J, Zappalla F, Balagopal PB, Falkner B, Kwiterovich P. A double-blind randomized trial of fish oil to lower triglycerides and improve cardiometabolic risk in adolescents. J Pediatr. 2014;165:497-503, e-pub 2014 July 7
  • 147. Widenhorn-Müller K, Schwanda S, Scholz E, Spitzer M, Bode H. Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): A randomized placebo-controlled intervention trial. Prostaglandins Leukot Essent Fatty Acids. 2014;91:49-60, e-pub 2014 May 28
  • 146. von Schacky C, Haslbauer R, Kemper M, Halle M. Low Omega-3 Index in 106 German elite winter endurance Athletes – A pilot study. International Journal of Sport Nutrition & Exercise Metabolism 2014;24:559-64, e-pub Sep 8
  • 145. Nosova EV, Chong KC, Alley HF, Harris WS, Boscardin WJ, Conte MS, Owens CD, Grenon SM. Clinical correlates of red blood cell omega-3 fatty acid content in male veterans with peripheral arterial disease. J Vasc Surg. 2014;60:1325-31, e-pub 2014 Jun 19
  • 144. Harris WS. Achieving optimal n–3 fatty acid status: the vegetarian’s challenge . . .or not. Am J Clin Nutr 2014;100(Suppl 1):449S-452S, e-pub 2014 June 4
  • 143. Gurzell EA, Wiesinger JA, Morkam C, Hemmrich S, Harris WS, Fenton JI. Is the omega-3 index a valid marker of intestinal membrane phospholipid EPA+DHA content? Prostaglandins Leukot Essent Fatty Acids. 2014;91:87-96, e-pub 2014 Apr 24.
  • 142. von Schacky C. Omega-3 Fatty Acids in Cardiovascular Disease - an Uphill Battle. PLEFA 2015;92:41-7 e-pub 2014 May 28
  • 141. von Schacky C. Nahrungsergänzung mit Omega-3 Fettsäuren? Herzmedizin 2014:31(3):6-10
  • 140. von Schacky C. Der HS-Omega 3 Index®: klinische Wertigkeit standardisierter Fettsäureanalytik. J Lab Med 2014;38:167-78
  • 139. Pottala JV, Djira GD, Espeland MA, Ye J, Larson MG, Harris WS. Structural equation modeling for analyzing erythrocyte fatty acids in Framingham. Comp Math Meth Med 2014;160520, e-pub 2014 April 15
  • 138. von Schacky C. Hirnstruktur und Hirnfunktion: Rolle der Omega-3 Fettsäuren. Z Orthomol Med 2014;1:20-4
  • 137. Dretsch MN, Johnston D, Bradley RS, Macrae H, Deuster PA, Harris WS. Effects of omega-3 Fatty Acid supplementation on neurocognitive functioning and mood in deployed u.s. Soldiers: a pilot study. Mil Med. 2014;179:396-403
  • 136. Sarter B, Kelsey KS, Schwartz TA, Harris WS. Blood docosahexaenoic acid and eicosapentaenoic acid in vegans: Associations with age and gender and effects of an algal-derived omega-3 fatty acid supplement. Clin Nutr. e-pub 2014 Mar 14.
  • 135. Fischer R, Konkel A, Mehling H, Blossey K, Gapelyuk A, Wessel N, von Schacky C, Dechend R, Muller DN, Rothe M, Luft FC, Weylandt K, Schunck WH. Dietary Omega-3 Fatty Acids Modulate the Eicosanoid Profile in Man Primarily via the CYP-epoxygenase Pathway. J Lipid Res 2014;55:1150-1164, e-pub 2014 Mar 16
  • 134. Harris WS, Pottala JV, Thiselton DL, A Varvel S, Baedke AM, Dayspring TD, Warnick GR, McConnell JP. Does APOE Genotype Modify the Relations Between Serum Lipid and Erythrocyte Omega-3 Fatty Acid Levels? J Cardiovasc Transl Res. 2014;7:526-32, e-pub 2014 Mar 5
  • 133. von Schacky C. Omega-3 Index for Cardiovascular Health. Nutrients 2014;6:799-814
  • 132. Berge K, Musa-Veloso K, Harwood M, Hoem N, Burri L. Krill Oil Supplementation lowers Serum Triglycerides without increasing low-density Lipoprotein Cholesterol in Adults with Borderline high or high Triglycerides. Nutr Res 2014;34:126-33
  • 131. Schuchardt JP, Schmidt S, Kressel G, Willenberg I, Hammock BD, Hahn A, Schebb NH. Modulation of blood oxylipin levels by long-chain omega-3 fatty acid supplementation in hyper- and normolipidemic men. Prostaglandins Leukot Essent Fatty Acids. 2014;90:27-37. Epub 2013 Dec 27.
  • 130. Harris WS, Schmitt TL. Unexpected similarity in RBC DHA and AA levels between bottlenose dolphins and humans. Prostaglandins Leukot Essent Fatty Acids. 2014;90:55-9. e-pub 2013 Dec 19
  • 129. Augustine AH, Lowenstein LM, Harris WS, Shearer GC, Block RC. Treatment with omega-3 fatty acid ethyl-ester alters fatty acid composition of lipoproteins in overweight or obese adults with insulin resistance. Prostaglandins Leukot Essent Fatty Acids. 2014;90:69-75. e-pub 2013 Dec 18
  • 128. Persons JE, Robinson JG, Ammann EM, Coryell WH, Espeland MA, Harris WS, Manson JE, Fiedorowicz JG. Omega-3 fatty acid biomarkers and subsequent depressive symptoms. Int J Geriatr Psychiatry. 2014;29:747-57, e-pub 2013 Dec 11
  • 127. Flock MR, Skulas-Ray AC, Harris WS, Etherton TD, Fleming JA, Kris-Etherton PM. Determinants of Erythrocyte Omega-3 Fatty Acid Content in Response to Fish Oil Supplementation: A Dose-Response Randomized Controlled Trial. J Am Heart Assoc. 2013;2:e000513.
  • 126. Pottala JV, Yaffe K, Robinson J, Espeland MA, Wallace R, Harris WS. Higher RBC EPA+DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study. Neurology 2014;82:435-42
  • 125. Jo S, An WS, Park Y. Erythrocyte n-3 Polyunsaturated Fatty Acids and the Risk of Type 2 Diabetes in Koreans: A Case-control Study. Ann Nutr Metab 2013;63:283-290
  • 124. Harris WS. Assessing Fatty Acid Biostatus: Red Blood Cells or Plasma? Lipid Technol 2013 (in press).
  • 123. Flock MR, Harris WS, Kris-Etherton PM. Long-chain dietary omega-3 fatty acids: Time to establish a dietary reference intake. Nutr Rev 2013;71:692-707
  • 122. Harris WS, Dayspring TD, Moran TJ. Omega-3 Fatty Acids and Cardiovascular Disease. New Developments and Applications. Postgrad Med 2013;125:100-113
  • 121. Baek D, Park Y. Association between erythrocyte n-3 polyunsaturated fatty acids and biomarkers of inflammation and oxidative stress in patients with and without depression. Prostaglandins Leukot Essent Fatty Acids. 2013;89:291-6, e-pub 2013 Sep 21
  • 120. Harris WS, Varvel SA, Pottala JV, Warnick GR, McConnell JP. The Comparative Effects Of An Acute Dose Of Fish Oil On Omega-3 Fatty Acid Levels in Red Blood Cells Versus Plasma: Implications for Clinical Utility. J Clin Lipidol 2013;7:433-440
  • 119. Ammann EM, Pottala JV, Harris WS, Espeland MA, Wallace R, Denburg NL, Carnahan RM, Robinson JG. Omega-3 fatty acids and domain-specific cognitive aging: Secondary analyses of data from WHISCA. Neurology. 2013;81:1484-91 e-pub 2013 Sep 25
  • 118. Grenon SM, Owens CD, Alley H, Chong K, Yen PK, Harris W, Hughes-Fulford M, Conte MS. n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial. Vasc Med. 2013;58:1283-90. e-pub 2013 Sep 19.
  • 117. Singhal A, Lanigan J, Storry C, Low S, Birbara T, Lucas A, Deanfield J. Docosahexaenoic acid supplementation, vascular function and risk factors for cardiovascular disease: a randomized controlled trial in young adults. J Am Heart Assoc. 2013 Jul 1;2(4):e000283.
  • 116. Lee AL, Park Y. The association between n-3 polyunsaturated fatty acid levels in erythrocytes and the risk of rheumatoid arthritis in Korean women. Ann Nutr Metab 2013;63:88-95
  • 115. Udani JK, Ritz BW. High potency fish oil supplement improves omega-3 fatty acid status in healthy adults: an open-label study using a web-based, virtual platform. Nutr J. 2013;12:112. [Epub ahead of print]
  • 114. Lemke SL, Maki KC, Hughes G, Taylor ML, Krul ES, Goldstein DA, Su H, Rains TM, Mukherjea R. Consumption of stearidonic Acid-rich oil in foods increases red blood cell eicosapentaenoic Acid. J Acad Nutr Diet. 2013;113:1044-56
  • 113. Kim TH, Jo S, Park Y, Lee HH, Chung SH, Lee WS. Differences in omega-3 and fatty acid profiles between patients with endometriosis and those with a functional ovarian cyst. J Obstet Gynaecol. 2013;33:597-600
  • 112. Park Y, Lee AR, Shim SC, Lee JH, Choe JY, Ahn H, Choi CB, Sung YK, Bae SC. Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea. J Nutr Biochem 2013; 24:1367–1372
  • 111. Grenon SM, Conte MS, Nosova E, Alley H, Chong K, Harris WS, Vittinghoff E, Owens CD. Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease. J Vasc Surg. 2013;58:1283-90, e-pub 2013 Jul 2.
  • 110. Metkus T, Timpone J, Leaf D, Bidwell Goetz M, Harris W, Brown T. Omega-3 fatty acid therapy reduces triglycerides and interleukin-6 in hypertriglyeridemic HIV patients. HIV Med. 2013;14:530-9, e-pub 2013 May 19.
  • 109. Schuchardt JP, Schmidt S, Kressel G, Dong H, Willenberg I, Hammock BD, Hahn A, Schebb NH. Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men. Prostaglandins Leukot Essent Fatty Acids. 2013;89:19-29, e-pub 2013 May 19
  • 108. Schuchardt JP, Hahn A. Bioavailability of long-chain omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2013;89:1-8. e-pub 2013 May 12
  • 107. Oelrich B, Dewell A, Gardner CD. Effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults. Nutr Metab Cardiovasc Dis. 2013;23:350-7
  • 106. Harris WS, Pottala JV, Varvel SA, Borowski JJ, Ward JN, McConnell JP. Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: Observations from 160,000 patients. Prostaglandins Leukot Essent Fatty Acids. 2013;88:257-63, e-pub 2013 Jan 30
  • 105. Oh JS, Kim SM, Sin YH, Kim JK, Park Y, Bae HR, Son YK, Nam HK, Kang HJ, An WS. Comparison of erythrocyte membrane Fatty Acid contents in renal transplant recipients and dialysis patients. Transplant Proc. 2012;44:2932-5, e-pub 2012 Nov 6.
  • 104. Harris WS. Are n-3 fatty acids still cardioprotective? Curr Opin Clin Nutr Metab Care. 2013;16:141-9, e-pub 2012 Nov 29
  • 103. von Schacky C. Meta-Analysing randomised controlled trials with omega-3 fatty acids in cardiovascular disease. Evidence based medicine, ebmed-2012-100960, e-pub Nov 17
  • 102. von Schacky C. Omega-3 Fettsäuren – HS-Omega-3 Index und Gesundheit von Herz und Hirn. Vitalstoffe 2012;2/4:28-36
  • 101. Harris WS, Kennedy KF, O'Keefe JH Jr, Spertus JA. Red blood cell fatty acid levels improve GRACE score prediction of 2-yr mortality in patients with myocardial infarction. Int J Cardiol. 2013;168:53-9, e-pub 2012 Oct 5.
  • 100. Schmidt S, Stahl F, Mutz KO, Scheper T, Hahn A, Schuchardt JP. Different gene expression profiles in normo- and dyslipidemic men after fish oil supplementation: results from a randomized controlled trial. Lipids Health Dis. 2012 Aug 29;11:105
  • 99. von Schacky C. Die Bedeutung des Omega-3 Index für den Sportler. Vitalstoffe 2012;2/2:47-51
  • 98. An WS, Lee SM, Son YK, Kim SE, Kim KH, Han JY, Bae HR, Rha SH, Park Y. Omega-3 fatty acid supplementation increases 1,25-dihydroxyvitamin D and fetuin-A levels in dialysis patients. Nutr Res. 2012;32:495-502. Epub 2012 Jul 20
  • 97. Skulas-Ray AC, Kris-Etherton PM, Harris WS, West SG. Effects of Marine-Derived Omega-3 Fatty Acids on Systemic Hemodynamics at Rest and During Stress: a Dose-Response Study. Ann Behav Med. 2012;44:301-8, e-pub 2012 Aug 4
  • 96. Schmidt S, Stahl F, Mutz KO, Scheper T, Hahn A, Schuchardt JP. Transcriptome-based identification of antioxidative gene expression after fish oil supplementation in normo- and dyslipidemic men. Nutr Metab (Lond). 2012 May 23;9(1):45
  • 95. Shearer GC, Pottala JV, Hansen SN, Brandenburg V, Harris WS. Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trial. J Lipid Res. 2012;53:2429-35. e-pub 2012 Aug 14
  • 94. Pottala JV, Espeland MA, Polreis J, Robinson J, Harris WS. Correcting the Effects of -20 °C Storage and Aliquot Size on Erythrocyte Fatty Acid Content in the Women's Health Initiative. Lipids. 2012;47:835-46. e-pub 2012 Jul 11
  • 93. Keenan AH, Pedersen TL, Fillaus K, Larson MK, Shearer GC, Newman JW. Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n3-HUFA in healthy volunteers. J Lipid Res. 2012;53:1662-9. e-pub 2012 May 24
  • 92. Johnston DT, Deuster PA, Harris WS, Macrae H, Dretsch MN. Red blood cell omega-3 fatty acid levels and neurocognitive performance in deployed U.S. Servicemembers. Nutr Neurosci. 2013;16:30-8, e-pub 2012 Jun 28
  • 91. Harris WS, Pottala JV, Lacey SM, Vasan RS, Larson MG, Robins SJ. Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study. Atherosclerosis. 2012;225:425-31. e-pub 2012 Jun 7.
  • 90. Voruganti VS, Higgins PB, Ebbesson SOE, Kennish J, Göring HHH, Haack K, Laston S, Drigalenko E, Wenger CR, Harris WS, Fabsitz RR, Devereux RB, MacCluer JW, Curran JE, Carless MA, Johnson MP, Moses EK, Blangero J, Umans JK, Howard BV, Cole SA, Comusszie AG. Variants in CPT1A, FADS1, and FADS2 are associated with higher levels of estimated plasma and erythrocyte delta-5 desaturases in Alaskan Eskimos. Front Genet 2012;3:86. e-pub 2012 Jun 11.
  • 89. Harris WS, Pottala JV, Vasan RS, Larson MG, Robins SJ. Changes in Erythrocyte Membrane Trans and Marine Fatty Acids between 1999 and 2006 in Older Americans. J Nutr. 2012;142:1297-303 e-pub 2012 May 23
  • 88. Park Y, Kim M, Baek D, Kim SH. Erythrocyte n-3 polyunsaturated fatty acids and seafood intake decrease risk of depression: Case-control study in Korea. Ann Nutr Metab 2012;61:25-31
  • 87. Block RC, Dier U, Calderonartero P, Shearer GC, Kakinami L, Larson MK, Harris WS, Georas S, Mousa SA. The Effects of EPA+DHA and Aspirin on Inflammatory Cytokines and Angiogenesis Factors. World J Cardiovasc Dis. 2012;2:14-19. e-pub 2011 Dec 30.
  • 86. von Schacky C. Omega-3 fatty acids: anti-arrhythmic, pro-arrhythmic, or both? Frontiers in Cardiac Electrophysiology, 2012;3: 98
  • 85. Moon HJ, Kim TH, Byun DW, Park Y. Positive correlation between erythrocyte levels of n-3 polyunsaturated fatty acids and bone mass in postmenopausal Korean women with osteoporosis. Ann Nutr Metab 2012;60:146-53
  • 84. Kim YJ, Jeong DW, Lee JG, Lee HC, Lee SY, Kim YJ, Yi YH, Park YS, Cho YH, Bae MJ, Choi EJ. Omega-3 index and smoking in patients with acute ST-elevation myocardial infarction taking statins: a case-control study in Korea. Lipids Health Dis. 2012;11:43
  • 83. Pottala JV, Churchill SW, Talley JA, Lynch DA, von Schacky C, Harris WS. Red Blood Cell Fatty Acids are Associated with Depression in a Case-Control Study of Adolescents. Prostaglandins Leukot Essent Fatty Acids 2012;86:161-5 e-pub 2012 Mar 28
  • 82. Tan ZS, Harris WS, Beiser AS, Au R, Himali JJ, Debette S, Pikula A, DeCarli CS, Wolf PA, Vasan RS, Robins SJ, Seshardi S. Red Blood Cell Omega-3 Fatty Acid Levels and Markers of Accelerated Brain Aging. Neurology 2012;78:658-64
  • 81. Billman GE, Carnes CA, Adamson PB, Vanoli E, Schwartz PJ. Dietary Omega-3 Fatty Acids and Susceptibility to Ventricular Fibrillation: Lack of Protection and A Proarrhythmic Effect. Circ Arrhythm Electrophysiol. 2012;5:553-60, e-pub 2012 Feb 14.
  • 80. Hussey EK, Portelli S, Fossler MJ, Gao F, Harris WS, Blum RA, Lates CD, Gould E, Abu-Baker O, Johnson S, Reddy KK. Relative bioavailability of an Emulsion Formulation for Omega-3-Acid Ethyl Esters Compared to the Commercially Available Formulation : A Randomized, Parallel-Group, Single-Dose Study Followed by Repeat dosing in healthy volunteers. Clin Pharm Drug Develop 2012;1:14-23
  • 79. An WS, Lee SM, Son YK, Kim SE, Kim KH, Han JY, Bae HR, Park Y. Effect of omega-3 fatty acids on the modification of erythrocyte membrane fatty acid content including oleic acid in peritoneal dialysis patients. Prostaglandins Leukot Essent Fatty Acids. 2012;86:29-34, e-pub 2011 Nov 7
  • 78. Krul ES, Lemke SL, Mukherjea R, Taylor ML, Goldstein DA, Su H, Liu P, Lawless A, Harris WS, Maki KC. Effects of duration of treatment and dosage of eicosapentaenoic acid and stearidonic acid on red blood cell eicosapentaenoic acid content. Prostaglandins Leukot Essent Fatty Acids 2012;86:51-9, e-pub 2011 Nov 5
  • 77. Shearer GC, Savinova OV, Harris WS. Fish oil: How does it reduce plasma triglycerides? Biochim Biophys Acta 2012;1821:843-51 e-pub 2011; e-pub 2011 Oct 25
  • 76. Harris WS. Stearidonic Acid as a ‘Pro-Eicosapentaenoic Acid’. Curr Opin Lipidol 2012;23:30-4, e-pub 2011 Dec 20
  • 75. Harris WS. Stearidonic Acid-Enhanced Soybean Oil: A Plant-Based Source of (n-3) Fatty Acids for Foods. J Nutr 2012;142:600S-4S. e-pub 2012 Jan 25
  • 74. Dewell A, Marvasti FF, Harris WS, Tsao P, Gardner CD. Dose-Dependent Effects of Plant and Marine Omega-3 Fatty Acids on Inflammatory Markers in Insulin Resistant Adults. A Randomized Controlled Trial. J Nutrition 2011;141:2166-71, e-pub 2011 Oct 26
  • 73. Salisbury AC, Harris WS, Amin AP, Reid KJ, O'Keefe Jr JH, Spertus JA. Relation Between Red Blood Cell Omega-3 Fatty Acid Index and Bleeding During Acute Myocardial Infarction. Am J Cardiol. 2012;109:13-8, e-pub 2011 Sep 23
  • 72. Maki KC, Bays HE, Dicklin MR, Johnson SL, Shabbout M. Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia. J Clin Lipidol. 2011;5:483-92. e-pub 2011 Sep 13.
  • 71. Ladesich JB, Pottala JV, Romaker A, Harris WS. Membrane levels of omega-3 docosahexaenoic acid is associated with obstructive sleep apnea. J Clin Sleep Med 2011;7:391-6
  • 70. Schuchardt JP, Neubronner J, Kressel G, Merkel A, von Schacky C, Hahn A. Moderate doses of EPA and DHA from re-esterified triacylglycerols but not from ethyl-esters lower fasting serum triacylglycerols in statin-treated dyslipidemic subjects: Results from a six month randomized controlled trial. Prostaglandins Leukot Essent Fatty Acids 2011;85:381-6, 2011, e-pub 2011 Aug 20
  • 69. Park Y, Moon HM, Kim SH. N-3 polyunsaturated fatty acid consumption produces neurobiological effects associated with prevention of depression in rats after the forced swimming test. J Nutr Biochem 2012;23:924-928
  • 68. von Schacky C. The Omega-3 Index as a Risk Factor for Cardiovascular Diseases. Prostaglandins and Other Lipid Mediators. 2011;96:94–8
  • 67. Park Y, Kim M. Serum 25-hydroxyvitamin D concentrations are associated with erythrocyte levels of n-3 PUFA but not risk of CVD. Br J Nutr. 2011;106:1529-34, e-pub 2011 Jun 1:1-6.
  • 66. Son YK, Lee SM, Kim SE, Kim KH, Lee SY, Bae HR, Han JY, Park Y, An WS. Association Between Vascular Calcification Scores on Plain Radiographs and Fatty Acid Contents of Erythrocyte Membrane in Hemodialysis Patients. J Ren Nutr. 2012;22:58-66, e-pub 2011 May 25
  • 65. Salisbury AC, Amin AP, Harris WS, Chan PS, Gosch KL, Rich MW, O'Keefe JH Jr, Spertus JA. Predictors of omega-3 index in patients with acute myocardial infarction. Mayo Clin Proc. 2011;86:626-32
  • 64. An WS, Son YK, Kim SE, Kim KH, Bae HR, Lee S, Park Y, Kim HJ, Vaziri ND. Association of adiponectin and leptin with serum lipids and erythrocyte omega-3 and omega-6 fatty acids in dialysis patients. Clin Nephrol. 2011;75:195-203.
  • 63. Billman GE, Harris WS. Effect of Dietary Omega-3 Fatty Acids on the Heart Rate and the Heart Rate Variability Response to Myocardial Ischemia or Submaximal Exercise. Am J Physiol Heart Circ Physiol. 2011;300:H2288-99, e-pub 2011 Apr 1
  • 62. Sala-Vila A, Harris WS, Cofán M, Pérez-Heras AM, Pintó X, Lamuela-Raventós RM, Covas MI, Estruch R, Ros E. Determinants of the omega-3 index in a Mediterranean population at increased risk for CHD. Br J Nutr. 2011;106:425-31, e-pub 2011 Mar 30:1-7
  • 61. Harris WS, Klurfeld DM. Twentieth-century trends in essential fatty acid intakes and the predicted omega-3 index: evidence versus estimates. Am J Clin Nutr. 2011;93:907-8, e-pub 2011 Mar 23
  • 60. Moyers B, Farzaneh-Far R, Harris WS, Garg S, Na B, Whooley MA. Relation of Whole Blood n-3 Fatty Acid Levels to Exercise Parameters in Patients With Stable Coronary Artery Disease (from the Heart and Soul Study). Am J Cardiol. 2011;107:1149-54, e-pub 2011 Feb 7
  • 59. Aarsetøy H, Aarsetøy R, Lindner T, Staines H, Harris WS, Nilsen DWT. Low Levels of the Omega-3 Index are Associated with Sudden Cardiac Arrest and Remain Stable in Survivors in the Subacute Phase. Lipids 2011;46:151-61.
  • 58. Chen J, Shearer GC, Chen Q, Healy CL, Beyer AJ, Nareddy VB, Gerdes AM, Harris WS, O'Connell TD, Wang D. Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cGMP/PKG signaling in cardiac fibroblasts. Circulation 2011;123:584-93
  • 57. Baghai TC, Varallo-Bedarida G, Born C, Häfner S, Schüle C, Eser D, Rupprecht R, Bondy B, von Schacky C. Major depression is associated with cardiovascular risk factors and low Omega-3 Index. J Clin Psychiat 2011;72:1242-7. Epub 2010 Dec 14.
  • 56. Kim M, Nam JH, Oh, DH Park Y. Erythrocyte a-linolenic acid is decreased the risk for mild dementia in Korean elderly. Nutr Res 2010;30:756-61
  • 55. Park Y, Oh SH, Rhee MY. Association between 24-hour ambulatory blood pressure and erythrocyte n-3 polyunsaturated fatty acids in Korean subjects with hypertension. Nutr Res 2010,30:807-14
  • 54. Yang R, Harris WS, Vernon K, Thomas AM, Qureshi N, Morrison DC, Van Way CW 3rd. Pre-feeding with omega-3 fatty acids suppresses inflammation following hemorrhagic shock. J Parenter Enteral Nutr. 2010;34:496-502.
  • 53. Skulas-Ray AC, Kris-Etherton PM, Harris WS, Vanden Heuvel JP, Wagner PR, West SG. Dose response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy people with moderate hypertriglyceridemia. Am J Clin Nutr 2011;93:243-52.
  • 52. Neubronner J, Schuchardt JP, Kressel G, Merkel M, von Schacky C, Hahn A. Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters. Eur J Clin Nutr. 2011;65:247-54.
  • 51. von Schacky C. Schwangerschaft, kindliche Entwicklung, Omega-3-Fettsäuren und HS-Omega-3 Index. J Frauengesundheit 2010;3:10-21.
  • 50. Harris WS. The Omega-3 Index: Clinical Utility for Therapeutic Intervention. Curr Cardiol Rep 2010;12:503-8.
  • 49. Lemke SL, Vicini JL, Su H, Goldstein DA, Nemeth MA, Krul ES, Harris WS. Dietary intake of stearidonic acid-enriched soybean oil increases the omega-3 index: randomized, double-blind clinical study of efficacy and safety. Am J Clin Nutr. 2010; 92:766-75.
  • 48. Carney RM, Freedland KE, Stein PK, Steinmeyer BC, Harris WS, Rubin EH, Krone RJ, Rich MW. Effect of Omega-3 Fatty Acids on Heart Rate Variability in Depressed Patients with Coronary Heart Disease. Psychosom Med 2010;72:748-54.
  • 47. Arnold C, Markovic M, Blossey K, Wallukat G, Fischer R, Dechend R, Konkel A, von Schacky C, Luft FC, Muller DN, Rothe M, Schunck WH. Arachidonic acid-metabolizing cytochrome P-450 enzymes are targets of omega-3 fatty acids. J Biol Chem, 2010;285:32720-33, e-pub 2010 Aug 23.08.10
  • 46. von Schacky C. Omega-3 Index and cardiovascular disease prevention: principle and rationale. Lipid Technology 2010;22:151-4.
  • 45. Pottala JV, Garg S, Cohen BE, Whooley MA, Harris WS. Blood Eicosapentaenoic and Docosahexaenoic Acids Predict All-Cause Mortality in Patients With Stable Coronary Heart Disease: The Heart and Soul Study. Circ Cardiovasc Qual Outcomes. 2010;3:406-12.
  • 44. Ebbesson SO, Devereux RB, Cole S, Ebbesson LO, Fabsitz RR, Haack K, Harris WS, Howard WJ, Laston S, Lopez-Alvarenga JC, MacCluer JW, Okin PM, Tejero ME, Voruganti VS, Wenger CR, Howard BV, Comuzzie AG. Heart rate is associated with red blood cell fatty acid concentration: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. Am Heart J. 2010;159:1020-5.
  • 43. Billman GE, Nishijima Y, Belevych AE, Terentyev D, Xu Y, Haizlip KM, Monasky MM, Hiranandani N, Harris WS, Gyorke S, Carnes CA, Janssen PM.. Effects of dietary omega-3 fatty acids on ventricular function in dogs with healed myocardial infarctions: in vivo and in vitro studies. Am J Physiol Heart Circ Physiol. 2010 Apr;298(4):H1219-28.
  • 42. Köhler A, Bittner D, Löw A, von Schacky C. Effects of a convenience drink fortified with n-3 fatty acids on the n-3 index. Br J Nutr 2010; 104:729-36.
  • 41. von Schacky C. Omega-3 Index and Sudden Cardiac Death. Nutritives 2010;2:375-8.
  • 40. von Schacky C. Omega-3 fatty acids vs. cardiac disease: the contribution of the omega-3 index. Cell Mol Biol 2010;56:90-8.
  • 39. Farzneh-Far R, Lin J, Epel ES, Harris WS, Blackburn EH, Whooley MA. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease JAMA 2010;303:250-7.
  • 38. Shearer GC, Chen J, Chen Y, Harris WS. Myocardial infarction does not affect fatty acid profiles in rats. Prostaglandins Leukot Essent Fatty Acids 2009; 81:411-6.
  • 37. Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris WS. Omega-3 Augmentation of Sertaline in Treatment of Depression in Patients with Coronary Heart Disease JAMA 2009;302:1651-53.
  • 36. Park Y, Lim J, Kwon Y, Lee J. Correlation of erythrocyte fatty acid composition and dietary intakes with markers of atherosclerosis in patients with myocardial infarction. Nutr Res. 2009;29:391-6.
  • 35. Harris WS. The Omega-3 Index: From Biomarker to Risk Marker to Risk Factor. Curr Athero Rep 2009;11:411-7.
  • 34. An WS, Kim SE, Kim KH, Lee S, Park Y, Kim HJ, Vaziri ND. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients. J Ren Nutr. 2009;19:267-74.
  • 33. Harris WS, Thomas RM. Biological variability of blood omega-3 biomarkers. Clin Biochem 2010;43:338-40, e-pub 2009 feb.
  • 32. Park Y, Park S, Yi H, Kim HY, Kang SJ, Kim J, Ahn H. Low level of n-3 polyunsaturated fatty acids in erythrocytes is a risk factor for both acute ischemic and hemorrhagic stroke in Koreans. Nutr Res. 2009;29:825-30.
  • 31. von Schacky C. Cardiovascular disease prevention and treatment. Prostaglandins Leukot Essent Fatty Acids 2009;81:193-8.
  • 30. Park Y, Lim J, Lee J, Kim SG. Erythrocyte fatty acid profiles can predict acute non-fatal myocardial infarction. Br J Nutr. 2009;102:1355-6.
  • 29. Aarsetoey H, Pönitz V, Grundt H, Staines H, Harris WS, Nilsen DW. (n-3) fatty acid content of red blood cells does not predict risk of future cardiovascular events following an acute coronary syndrome. J Nutr 2009;139:507-13.
  • 28. Shearer GC, Pottala JV, Spertus JA, Harris WS. Red Blood Cell Fatty Acid Patterns and Acute Coronary Syndrome. PLoS ONE 2009;4: e5444. doi:10.1371/journal.pone.0005444.
  • 27. Ali S, Garg SK, Cohen BE, Bhave P, Harris WS, Whooley MA. Association between omega-3 fatty acids and depressive symptoms among patients with established coronary artery disease: Data from the Heart and Soul Study. Psychother Psychosom. 2009;78:125-7.
  • 26. Duda MK O'Shea KM, Tintinu A, Xu W, Khairallah RJ, Barrows BR, Chess DJ, Azimzadeh AM, Harris WS, Sharov VG, Sabbah HN, Stanley WC. Fish oil but not flaxseed oil decreases inflammation and prevents pressure-overload induced cardiac dysfunction. Cardiovasc Res 2009;81:319-27.
  • 25. von Schacky C. Use of red cell fatty acid profiles as biomarkers in cardiac disease Biomark Med 2009;3:25-32.
  • 24. Harris WS, Lemke SL, Hansen SN, Goldstein DA, DiRienzo MA, Su H, Nemeth MA, Taylor ML, Ahmed G, George C. Stearidonic Acid-Enriched Soybean Oil Increased the Omega-3 Index, an Emerging Cardiovascular Risk Marker. Lipids 2008;43:805-11.
  • 23. Larson MK, Ashmore JH, Harris KA, Vogelaar JL, Pottala JV, Sprehe M, Harris WS. Effects of Omega-3 Acid Ethyl Esters and Aspirin, Alone and in Combination, on Platelet Function in Healthy Subjects. Thromb Haemost 2008;100:634-41.
  • 22. Farzaneh-Far R, Harris WS, Garg S, Na B, Whooley MA. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in stable coronary artery disease: The Heart and Soul Study. Atherosclerosis 2009;205:538-43.
  • 21. Cohen BE, Garg SK, Ali S, Harris WS, Whooley MA. Red blood cell EPA and DHA concentrations are positively associated with Socioeconomic status in patients with established coronary artery disease: Data from the Heart and Soul Study. J Nutrition 2008;138:1135-40.
  • 20. Block RC, Harris WS, Pottala JV. Determinants of blood cell omega-3 fatty acid content. The Open Biomarkers J 2008;1:1-6.
  • 19. Block RC, Harris WS, Reid KJ, Spertus JA.Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes? Am Heart J. 2008;156:1117-23.
  • 18. Block RC, Harris WS, Reid KJ, Sands SA, Spertus JA. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis 2008;197:821-8.
  • 17. Amin AA, Menon RA, Reid KJ, Harris WS, Spertus JA. Acute Coronary Syndrome Patients With Depression Have Low Blood Cell Membrane Omega-3 Fatty Acid Levels. Psychosom Med 2008;70:856-62.
  • 16. von Schacky C. Omega-3 fatty acids pro-arrhythmic, anti-arrhythmic or both ? Curr Op Nutr Metab Care 2008;11:94-9.
  • 15. Lee E, Lee S, Park Y. n-3 Polyunsaturated fatty acids and trans fatty acids in patients with the metabolic syndrome: a case-control study in Korea. Br J Nutr 2008;100:609-14.
  • 14. Harris WS, von Schacky C. N-3 Fatty Acids, Acute Coronary Syndrome, and Sudden Death. Curr Cardiovasc Risk Rpt 2008;2:161-6.
  • 13. Hwang I, Cha A, Lee H, Yoon H, Yoon T, Cho B, Lee S, Park Y. n-3 Polyunsaturated Fatty Acids and Atopy in Korean Preschoolers. Lipids 2007;42:345-9
  • 12. Aarsetoey H, Pönitz V, Nilsen OB, Grundt H, Harris WS, Nilsen DW. Low levels of cellular omega-3 increases the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction. Resuscitation 2008;78:258-64.
  • 11. Harris WS, Pottala JV, Sands SA, Jones PG. Comparison of the effects of fish and fish oil capsules on the n-3 fatty acid content of blood cells and plasma phospholipids. Am J Clin Nutr 2007;86:1621-25.
  • 10. Harris WS, Reid KJ, Sands SA, Spertus JA. Blood Omega-3 and Trans Fatty Acids in Middle-Aged Acute Coronary Syndrome Patients. Am J Cardiol 2007;99:154-8.
  • 9. von Schacky C, Harris WS. Cardiovascular Risk and the Omega-3 Index. J Cardiovasc Med 2007;8 (suppl 1):S46-9.
  • 8. Harris WS, Poston WC, Haddock CK. Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 193:1-10, 2007.
  • 7. Harris WS, DiRienzo MA, Sands SA, George C, Jones PG, Eapen AK. Stearidonic Acid Supplementation Increases Red Blood Cell and Heart Omega 3 Index in Dogs. Lipids 42:325-33, 2007.
  • 6. Harris WS. Omega-3 Fatty Acids and Cardiovascular Disease. A case for the Omega-3 Index as a New Risk Factor. Pharmacol Res 2007;55:217-23
  • 5. von Schacky C. Omega-3 Fettsäuren in der Kardiologie – neueste Entwicklungen. Münch Med Wochenschr 2007;149:97-101.
  • 4. Harris WS, Gonzales M, Laney N, Sastre A, Borkon AM. Effects of Omega-3 Fatty Acids on Heart Rate in Cardiac Transplant Recipients. Am J Cardiol 2006;98:1393-5.
  • 3. Sands SA, Reid KJ, Windsor SL, Harris WS. The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids 2005;40:343-7.
  • 2. Harris WS, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, Porter CB, Borkon AM. Omega-3 Fatty Acid Levels in Transplanted Human Hearts: Effect of Supplementation and Comparison with Erythrocytes. Circulation 2004;110;1645-9.
  • 1. Harris WS and von Schacky C. The Omega-3 Index: A New Risk Factor for Death from CHD? Preventive Medicine 2004;39:212-20.

Chapters in Books / Buchkapitel

  • von Schacky C. Prevention of cardiovascular disease – what can we learn from epidemiology? In Omega-3 Fatty Acids and Cardiovascular Diseases; von Schacky C, ed., Uni-Med Verlag, Bremen, London, Boston, 2010, p 22-25
  • Harris WS, von Schacky C. The omega-3 index in clinical research and medicine. In Omega-3 Fatty Acids and Cardiovascular Diseases; von Schacky C, ed., Uni-Med Verlag, Bremen, London, Boston, 2010, p 72-80
  • von Schacky C. Mechanisms of action of omega-3 fatty acids. Effects on cardiac rhythm. In Omega-3 Fatty Acids and Cardiovascular Diseases; von Schacky, C, ed., Uni-Med Verlag, Bremen, London, Boston, 2010, p 32-35
  • von Schacky C. Large clinical trials in patients with coronary artery disease or equivalent risk. In Omega-3 Fatty Acids and Cardiovascular Diseases; von Schacky, C, ed., Uni-Med Verlag, Bremen, London, Boston, 2010, p 44-50
  • von Schacky C. Prävention kardiovaskulärer Erkrankungen – was lehrt uns die Epidemiologie? In Omega-3 Fettsäuren und kardiovaskuläre Erkrankungen; von Schacky C, ed., Uni-Med Verlag, Bremen, London, Boston, 2012, p 12-25
  • von Schacky C. Wirkmechanismen von Omega-3 Fettsäuren und Interventionsstudien mit < 200 Teilnehmern. In Omega-3 Fettsäuren und kardiovaskuläre Erkrankungen; von Schacky C, ed., Uni-Med Verlag, Bremen, London, Boston, 2012, p 26-49
  • von Schacky C. Große Klinische Interventionsstudien bei Patienten mit kardialen Erkrankungen. In Omega-3 Fettsäuren und kardiovaskuläre Erkrankungen; von Schacky C, ed., Uni-Med Verlag, Bremen, London, Boston, 2012, p 50-67
  • von Schacky C. HS-Omega-3 Index in Forschung und Klinik. In Omega-3 Fettsäuren und kardiovaskuläre Erkrankungen; von Schacky C, ed., Uni-Med Verlag, Bremen, London, Boston, 2012, p 82-97
  • von Schacky C. Andere Wirkungen von Omega-3 Fettsäuren. In Omega-3 Fettsäuren und kardiovaskuläre Erkrankungen; von Schacky C, ed., Uni-Med Verlag, Bremen, London, Boston, 2012, p 98-101
  • von Schacky C. Optimal Omega-3 Levels for different age groups In Omega-6/3 Fatty acids – Functions, Sustainability Strategies, and Perspectives; De Meester F, Watson RR, Zidadi S, ed., Humana Press, Nutrition and Health Series (Bendich A ed.), 2013, p 53-64
  • Harris WS, von Schacky C, Park Y. Standardizing Methods for Assessing Omega-3 Fatty Acid Biostatus. In The Omega-3 Fatty Acid Deficiency Syndrome; McNamara RK ed., Nova Science Publishers 2013
  • von Schacky C. Convenience Drinks Fortified with n-3 Fatty Acids: A Systematic Review. In Nutrition and Health (Series Editor: Adrianne Bendich), Handbook of Food Fortification – From Concepts to Public Health Applications Volume 2, Preedy VR, Srirajaskanthan R, Patel VB, eds., Humana Press, 2013, p 95-103